Qing Zhang1, Zheng Wen2,3,4,5, Ming Ni2,3,4,5, Da Li2,3,4,5, Ke Wang2,3,4,5, Gui-Jun Jia2,3,4,5, Zhen Wu2,3,4,5, Li-Wei Zhang2,3,4,5, Wang Jia2,3,4,5, Liang Wang2,3,4,5, Jun-Ting Zhang2,3,4,5. 1. Department of Neurosurgery, Chinese People's Liberation Army General Hospital, Beijing, China. 2. Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing, China. 3. China National Clinical Research Center for Neurological Diseases, Beijing, China. 4. Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China. 5. Beijing Key Laboratory of Brain Tumor, Beijing, China.
Abstract
OBJECTIVE: To investigate the independent risk factors for recurrence in intracranial atypical meningiomas (AMs) treated with gross total resection (GTR) and early external beam radiotherapy (EBRT). METHODS: Clinical, radiological, and pathological data of intracranial AMs treated with GTR-plus-early-EBRT between January 2008 and July 2016 were reviewed. Immunohistochemical staining for Ki-67 was performed. Kaplan-Meier curves and univariate and multivariate Cox proportional hazards regression analyses were used to explore independent predictors of tumor recurrence. Chi square test was performed to compare variables between subgroups. RESULTS: Forty-six patients with intracranial AMs underwent GTR and early EBRT. Ten (21.7%) recurred and three (6.5%) died during a median follow-up of 76.00 months. Univariate and multivariate Cox analyses revealed that malignant progression (MP) (P = 0.009) was the only independent predictor for recurrence, while Ki-67 was of minor value in this aspect (P = 0.362). MP-AMs had a significantly higher recurrence rate (P = 0.008), a higher proportion of irregularly shaped tumors (P = 0.013) and significantly lower preoperative Karnofsky Performance Scale (KPS) scores (P = 0.040) than primary (Pri) AMs. No significant difference in Ki-67 expression was detected between these subgroups (P = 0.713). CONCLUSIONS: MP was significantly correlated with an increased incidence of recurrence in GTR-plus-early-EBRT-treated intracranial AMs. Significantly higher frequencies of tumor relapse and irregularly shaped tumors and lower preoperative KPS scores were observed in MP-AMs compared with Pri-AMs. Ki-67 expression is of minor value in predicting tumor recurrence or distinguishing tumor origins in AMs.
OBJECTIVE: To investigate the independent risk factors for recurrence in intracranial atypical meningiomas (AMs) treated with gross total resection (GTR) and early external beam radiotherapy (EBRT). METHODS: Clinical, radiological, and pathological data of intracranial AMs treated with GTR-plus-early-EBRT between January 2008 and July 2016 were reviewed. Immunohistochemical staining for Ki-67 was performed. Kaplan-Meier curves and univariate and multivariate Cox proportional hazards regression analyses were used to explore independent predictors of tumor recurrence. Chi square test was performed to compare variables between subgroups. RESULTS: Forty-six patients with intracranial AMs underwent GTR and early EBRT. Ten (21.7%) recurred and three (6.5%) died during a median follow-up of 76.00 months. Univariate and multivariate Cox analyses revealed that malignant progression (MP) (P = 0.009) was the only independent predictor for recurrence, while Ki-67 was of minor value in this aspect (P = 0.362). MP-AMs had a significantly higher recurrence rate (P = 0.008), a higher proportion of irregularly shaped tumors (P = 0.013) and significantly lower preoperative Karnofsky Performance Scale (KPS) scores (P = 0.040) than primary (Pri) AMs. No significant difference in Ki-67 expression was detected between these subgroups (P = 0.713). CONCLUSIONS: MP was significantly correlated with an increased incidence of recurrence in GTR-plus-early-EBRT-treated intracranial AMs. Significantly higher frequencies of tumor relapse and irregularly shaped tumors and lower preoperative KPS scores were observed in MP-AMs compared with Pri-AMs. Ki-67 expression is of minor value in predicting tumor recurrence or distinguishing tumor origins in AMs.
Authors: Jennifer Moliterno; William P Cope; Emma D Vartanian; Anne S Reiner; Roselyn Kellen; Shahiba Q Ogilvie; Jason T Huse; Philip H Gutin Journal: J Neurosurg Date: 2015-04-10 Impact factor: 5.115
Authors: R G Weber; J Boström; M Wolter; M Baudis; V P Collins; G Reifenberger; P Lichter Journal: Proc Natl Acad Sci U S A Date: 1997-12-23 Impact factor: 11.205
Authors: M Simon; A von Deimling; J J Larson; R Wellenreuther; P Kaskel; A Waha; R E Warnick; J M Tew; A G Menon Journal: Cancer Res Date: 1995-10-15 Impact factor: 12.701
Authors: Gurvinder Kaur; Eli T Sayegh; Andrew Larson; Orin Bloch; Michelle Madden; Matthew Z Sun; Igor J Barani; C David James; Andrew T Parsa Journal: Neuro Oncol Date: 2014-04-02 Impact factor: 12.300